Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2010
08/19/2010US20100210726 Composition for promoting ketone body production
08/19/2010US20100210723 Lipase inhibitor
08/19/2010US20100210722 Composition for preventing or treating lipid metabolic disorders comprising fucoxanthin or marine plant extract containing same
08/19/2010US20100210718 Synergistic anti-oxidant treatment for lipotoxicity and other metabolically related phenomena
08/19/2010US20100210716 Process for Preparing an Alpha-Lipoic Acid/Cyclodextrin Complex and Product Prepared
08/19/2010US20100210692 Methods of treatment using sirt modulators and compositions containing sirt1 modulators
08/19/2010US20100210690 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210680 Tricyclic heterocyclic derivatives
08/19/2010US20100210666 Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy
08/19/2010US20100210662 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
08/19/2010US20100210661 Stat3/5 activation inhibitor
08/19/2010US20100210660 Heterocyclic FXR Binding Compounds
08/19/2010US20100210658 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
08/19/2010US20100210656 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210655 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210653 Novel Compounds, Their Preparations and Use
08/19/2010US20100210646 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
08/19/2010US20100210640 Benzamide derivatives, their preparation and uses in medicine thereof
08/19/2010US20100210638 Modulators of atp-binding cassette transporters
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210636 Benzoxazinone derivative
08/19/2010US20100210633 Carboxamide compounds and their use
08/19/2010US20100210628 NOVEL sEH INHIBITORS AND THEIR USE
08/19/2010US20100210624 Aryloxy- and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
08/19/2010US20100210621 Crystalline polymorphic form 631
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210618 Piperidine/piperazine derivatives
08/19/2010US20100210595 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus
08/19/2010US20100210594 Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type i and ii diabetes mellitus
08/19/2010US20100210586 Pomegranate extracts, nutritional products containing them and their uses
08/19/2010US20100210582 Method and composition for treating patients with a high risk of developing neuro-immune disorders or developmental delays, identified through the utilization of low homocysteine or its precursors/metabolites, as the predictor of such risk
08/19/2010US20100210579 Partial and full agonists of a1 adenosine receptors
08/19/2010US20100210568 Thyrotropin releasing hormone for therapeutic applications
08/19/2010US20100210556 Use of a peptide as a therapeutic agent
08/19/2010US20100210555 Use of a laminin peptide as a therapeutic agent
08/19/2010US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/19/2010US20100210541 Biomarkers for Appetite Regulation
08/19/2010US20100210540 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent
08/19/2010US20100210539 Use of peptide ll-37 as a therapeutic agent
08/19/2010US20100210538 Therapeutic uses of intermedin 47 and 53 peptides
08/19/2010US20100210537 Use of a defensin peptide as a therapeutic agent
08/19/2010US20100210535 Therapeutic use of neuropeptide ei and acth 7-38 and compositions thereof
08/19/2010US20100210524 Novel estrogen receptor ligands
08/19/2010US20100210512 Thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
08/19/2010US20100210506 Intranasal administration of rapid acting insulin
08/19/2010US20100210505 Polymer conjugates of glp-1
08/19/2010US20100209536 Methods and Kits for Use in the Treatment and Prevention of Diseases or Conditions of the Immune System or Infectious Diseases
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209513 Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
08/19/2010US20100209510 Extended Release Formulation and Method of Treating Adrenergic Dysregulation
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209506 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
08/19/2010US20100209502 Treatments Which Alleviate Functional Glycosylated Leptin Transport Factor for Controlling Weight and Obesity
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100209468 Implantable devices for producing insulin
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209441 Drug for suppressing pathogen occurring in vivo
08/19/2010US20100209427 Lysine acetylation sites
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209385 Treatment of obesity
08/19/2010US20100209384 Sustained release formulations comprising very low molecular weight polymers
08/19/2010US20100209382 Polyphenol Conjugates as RGD-Binding Compounds and Methods of Use
08/19/2010US20100209350 Biomarkers for Adipose Tissue Activity
08/19/2010CA2752437A1 Antidiabetic medications
08/19/2010CA2752435A1 Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
08/19/2010CA2752434A1 Pharmaceutical composition comprising linagliptin and a sglt2 inhibitor
08/19/2010CA2752199A1 3-benzofuranyl-indol-2-one derivatives substituted at the 3 position, preparation thereof, and therapeutic use thereof
08/19/2010CA2752198A1 Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751834A1 Pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally a further antidiabetic agent and uses thereof
08/19/2010CA2751833A1 Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabete mellitus, impaired glucose tolerance or hyperglycemia
08/19/2010CA2751576A1 Methods of treating hypertriglyceridemia
08/19/2010CA2751385A1 Novel salts of sitagliptin
08/19/2010CA2749994A1 Crystalline polymorphic form 631
08/18/2010EP2219031A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
08/18/2010EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction
08/18/2010EP2218721A1 Novel salts of sitagliptin
08/18/2010EP2218337A1 Mimicking the metabolic effects of caloric restriction by administration of glucose anti-metabolites
08/18/2010EP2217606A1 Solubilized thiazolopyridines
08/18/2010EP2217596A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
08/18/2010EP2217583A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
08/18/2010EP2217255A2 Use of phytoecdysones in the preparation of a composition for acting on metabolic syndrome
08/18/2010EP2217239A2 Modulation of protein trafficking
08/18/2010EP2217232A1 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465
08/18/2010EP2217067A1 Method and compounds for modulating insulin production
08/18/2010EP1979355B1 Spiro imidazole derivatives as ppar modulators
08/18/2010EP1951692B1 Oxazole and thiazole ppar modulator
08/18/2010EP1735275B1 Aryl sulfones and uses related thereto
08/18/2010EP1709049B1 Bicyclic imidazole compounds, the production thereof and their use as medicaments
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1351963B1 A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
08/18/2010EP1121115B2 Pufa supplements
08/18/2010CN1837202B Flavonols with blood-fat-lowering effect
08/18/2010CN1835752B Multivitamin syrup for children or young adults
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101808642A Mast cell stabilizers in the treatment of obesity
08/18/2010CN101808533A Dietary fiber composition comprising glucomannan, xanthan gum, alginate and lipid
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 1298